PDR Drug Updates
Get more information on PDR's monthly Drug Updates, including the latest in FDA news and drug labeling updates.
2023 eDrug Updates
- September 2023: Slowing the Decline Seen with Alzheimer's Disease
- August 2023: Fighting the Effects of Meibomian Gland Dysfunction
- July 2023: Managing Menopause-Associated Vasomotor Symptoms Via New Nonhormonal Therapy
- June 2023: Important New Tools for Opioid Misuse Intervention
- May 2023: Closing Treatment Gaps for Candidemia and Invasive Candidiasis
- April 2023: Alternative CGRP Option for Migraineurs
- March 2023: Increased Precision in Ovarian Cancer Therapy
- February 2023: Combating Recurrent CDI with First-in-Class Live Biotherapeutic
- January 2023: Taking a Step Closer to Ending Type 1 Diabetes